Publication:
Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.

Simple item page
dc.contributor.authorJannuzzi A. T.
dc.contributor.authorKorkmaz N. S.
dc.contributor.authorGunaydin Akyildiz A.
dc.contributor.authorArslan Eseryel S.
dc.contributor.authorKarademir Yilmaz B.
dc.contributor.authorAlpertunga B.
dc.contributor.institutionauthorGÜNAYDIN AKYILDIZ, AYŞENUR
dc.date.accessioned2023-02-24T21:30:28Z
dc.date.available2023-02-24T21:30:28Z
dc.date.issued2023-02-21
dc.identifier.citationJannuzzi A. T., Korkmaz N. S., Gunaydin Akyildiz A., Arslan Eseryel S., Karademir Yilmaz B., Alpertunga B., "Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.", Cardiovascular toxicology, 2023
dc.identifier.doi10.1007/s12012-023-09785-7
dc.identifier.issn1530-7905
dc.identifier.pubmed36809482
dc.identifier.urihttps://hdl.handle.net/20.500.12645/37112
dc.relation.ispartofCardiovascular toxicology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleMolecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.
dc.typearticle
dspace.entity.typePublication
local.avesis.id78329ed3-2a8b-4813-b945-55c14ef36a3e
relation.isAuthorOfPublication98a70592-2158-4e37-b8d7-80d3bd64c98c
relation.isAuthorOfPublication.latestForDiscovery98a70592-2158-4e37-b8d7-80d3bd64c98c
Files
Collections
Yayınlar - Eserler